Related Experiment Videos
NAT2 gene polymorphism in bladder cancer: a study from North India
Rama D Mittal1, Daya S L Srivastava, Anil Mandhani
1Department of Urology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India. rmittal@sgpgi.ac.in
Summary
The NAT2 genotype, which influences how the body processes substances, was not found to be a significant risk factor for bladder cancer in North Indian individuals. This study also found no association between NAT2 genotype and tobacco use in relation to bladder cancer risk.
Area of Science:
- Genetics
- Oncology
- Pharmacogenomics
Background:
- Bladder cancer is a significant global health concern.
- Genetic variations, such as those in the NAT2 gene, may influence individual susceptibility to cancer.
- N-acetyltransferase 2 (NAT2) genotypes play a role in metabolizing various compounds, including carcinogens found in tobacco smoke.
Purpose of the Study:
- To investigate the association between NAT2 genotypes and bladder cancer risk.
- To explore the potential interaction between NAT2 genotype and tobacco usage in bladder cancer development.
Main Methods:
- A case-control study involving 101 bladder cancer patients and 110 controls.
- NAT2 genotyping performed using the PCR-RFLP method on peripheral blood DNA.
- Statistical analysis using Chi-squared and Fisher exact tests to compare genotype frequencies.
Main Results:
- No significant difference in the frequency of NAT2 fast or slow acetylator genotypes was observed between bladder cancer patients and controls (p > 0.05).
- The combination of NAT2 genotype and tobacco use did not show a statistically significant association with bladder cancer risk (p > 0.05).
Conclusions:
- NAT2 genotypes are not associated with an increased risk of developing bladder cancer in the studied North Indian population.
- The findings suggest that NAT2 polymorphism does not modify bladder cancer risk in conjunction with tobacco consumption in this cohort.